Failure to fill electronically prescribed antidepressant medications: A retrospective study

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 13, Issue 1, 2011, Pages

  Xing, Shan ^a,e   DiPaula, Bethany A ^a,b   Lee, Helen Y ^c   Cooke, Catherine E ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Springfield Hospital Center   (United States)

^c CareFirst   (United States)

^d PosiHealth   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG TREATMENT FAILURE; DRUG USE; ELECTRONIC PRESCRIBING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACY; RETROSPECTIVE STUDY;

EID: 79952786346     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.10m00998blu     Document Type: Article

References (30)

1. World Health Organization. The World Health Report 2001: mental health: new understanding, new hope. http://www.who.int/whr. Accessed February 20, 2010
2. World Health Organization. The World Health Report 2004: changing history, annex table 3: burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions, estimates for 2002. http://www.who.int/whr/2004/en/09_annexes_en.pdf. Accessed September 15, 2010
3. Rihmer Z. Can better recognition and treatment of depression reduce suicide rates? a brief review. Eur Psychiatry. 2001;16(7):406-409. PubMed doi:10.1016/S0924-9338(01)00598-3
4. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108(10):1893-1900, discussion 1900-1901. PubMed doi:10.1016/S0161-6420(01)00754-0
5. Bogner HR, Morales KH, Post EP, et al. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care. 2007;30(12):3005-3010. PubMed doi:10.2337/dc07-0974
6. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768-1775. PubMed doi:10.1161/CIRCULATIONAHA.108.190769
7. de Voogd JN, Wempe JB, Koëter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619-625. PubMeddoi:10.1378/chest.08-0078
8. Nimalasuriya K, Compton MT, Guillory VJ; Prevention Practice Committee of the American College of Preventive Medicine. Screening adults for depression in primary care: a position statement of the American College of Preventive Medicine. J Fam Pract. 2009;58(10):535-538. PubMed
9. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848-856. PubMed doi:10.1001/archgenpsychiatry.2009.81
10. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder (revision): American Psychiatric Association. Am J Psychiatry. 2000;157(4 suppl):1-45. PubMed
11. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303-312. PubMed
12. Esposito D, Schone E, Williams T, et al. Prevalence of unfilled prescriptions at military pharmacies. J Manag Care Pharm. 2008;14:553-560. PubMed
13. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560. PubMed
14. Bull SA, Hunkeler EM, Lee JY, et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother. 2002;36(4):578-584. PubMeddoi:10.1345/aph.1A254
15. Dunn RL, Donoghue JM, Ozminkowski RJ, et al. Selective serotonin reuptake inhibitor antidepressant prescribing in primary care in the United Kingdom: a longitudinal analysis. Prim Care Psychiatry. 1998;4:141-148.
16. Fairman KA, Drevets WC, Kreisman JJ, et al. Course of antidepressant treatment drug type, and prescriber's specialty. Psychiatr Serv. 1998;49(9):1180-1186. PubMed
17. Akincigil A, Bowblis JR, Levin C, et al. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45(4):363-369. PubMed doi:10.1097/01.mlr.0000254574.23418.f6
18. Sirey JA, Meyers BS, Bruce ML, et al. Predictors of antidepressant prescription and early use among depressed outpatients. Am J Psychiatry. 1999;156(5):690-696. PubMed
19. van Geffen EC, Gardarsdottir H, van Hulten R, et al. Initiation of antidepressant therapy: do patients follow the GP's prescription? Br J Gen Pract. 2009;59(559):81-87. PubMed doi:10.3399/bjgp09X395067
20. Vanelli M, Coca-Perraillon M. Role of patient experience in antidepressant adherence: a retrospective data analysis. Clin Ther. 2008;30(9):1737-1745. PubMeddoi:10.1016/j.clinthera.2008.08.014
21. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiology Survey on Alcoholism and Related Disorders. Arch Gen Psychiatry. 2005;62(10):1097-1106. PubMeddoi:10.1001/archpsyc.62.10.1097
22. Office of Applied Studies. (2007). Results from the 2007 National Survey on Drug Use and Health: National findings. DHHS Publication, 2009. http://oas.samhsa.gov/NSDUH/2k7NSDUH/2k7results.cfm#Ch8. Accessed June 30, 2009
23. Rickles NM, Svarstad BL. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Adm Pharm. 2007;3(4):363-377. PubMed
24. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33(1):67-74. PubMeddoi:10.1097/00005650-199501000-00006
25. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321. PubMed doi:10.1001/archinte.166.21.2314
26. Williams JW Jr, Gerrity M, Holsinger T, et al. Systematic review of multifaceted interventions to improve depression care. Gen Hosp Psychiatry. 2007;29(2):91-116. PubMed doi:10.1016/j.genhosppsych.2006.12.003
27. Bucci KK, Possidente CJ, Talbot KA. Strategies to improve medication adherence in patients with depression. Am J Health Syst Pharm. 2003;60(24):2601-2605. PubMed
28. Demyttenaere K, Enzlin P, Dewé W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62(suppl 22):30-33. PubMed
29. Mabotuwana T, Warren J, Harrison J, et al. What can primary care prescribing data tell us about individual adherence to long-term medication? comparison to pharmacy dispensing data. Pharmacoepidemiol Drug Saf. 2009;18(10):956-964. PubMeddoi:10.1002/pds.1803
30. Schoen C, DesRoches C. Uninsured and unstably insured: the importance of continuous insurance coverage. Health Serv Res. 2000;35(1 pt 2):187-206. PubMed